Holly Noftall (@hollynoftall) 's Twitter Profile
Holly Noftall

@hollynoftall

ID: 2949281681

calendar_today29-12-2014 14:09:27

15 Tweet

17 Takipçi

108 Takip Edilen

Kara O'Keefe, PharmD (@kara_okeefe) 's Twitter Profile Photo

RT if you support expanding the scope of practice of pharmacists in Newfoundland & Labrador. #TwitteRx #Pharmacy #Pharmacist #nlpoli John Haggie PANL @nlpharmacyboard Andrew Furey @HealthAccordNL

Holly Noftall (@hollynoftall) 's Twitter Profile Photo

A study from Taiwan discussing requirements for implementation and perceptions of Pharmacist-managed clinics (PMCs) #PHAR4902F22 mun.primo.exlibrisgroup.com/discovery/full…

PANL (@panlupdates) 's Twitter Profile Photo

NL pharmacists could be playing a bigger role in the healthcare system if they could practice to their FULL SCOPE. To view PANL’s Health Accord NL presentations visit panl.net/2021-news-arch… Health and Community Services NL Tom Osborne LIB

NL pharmacists could be playing a bigger role in the healthcare system if they could practice to their FULL SCOPE. To view PANL’s Health Accord NL presentations visit panl.net/2021-news-arch… <a href="/HCS_GovNL/">Health and Community Services NL</a> <a href="/TomOsborneMHA/">Tom Osborne LIB</a>
The Pharmaceutical Journal (@pjonline_news) 's Twitter Profile Photo

University launches first distance-learning independent prescriber course for pharmacists pharmaceutical-journal.com/article/news/u…

Pharmacy & Acute Care University (@pharmacyacute) 's Twitter Profile Photo

We will be having our our clinical skills competition called “The Challenge” next week. This will be for all healthcare professionals. 3 days of timed pharmacotherapy quizzes and prizes. Like and share this post if you think this will be exciting. #TwitteRx #EMRx #pharmRes

Sahil Bloom (@sahilbloom) 's Twitter Profile Photo

I recently came across data on who we spend our time with over the course of our lives. The insights are simultaneously inspiring and depressing. Here are 6 graphs everyone needs to see:

Dr Joshua Walinjom (@walinjom) 's Twitter Profile Photo

Sacubitril-valsartan is considered in heart failure patients with a LVEF < 35% who are still symptomatic on ACE-inhibitors & beta-blockers.